Pharmacoeconomics

Health economics is a tool to help us prioritise different and sometimes competing health care interventions for these fixed resources and, in doing so, health care is treated as a commodity like any other. Knowledge of health economics coupled with political insight is essential to understand resource allocation and expenditure in a modern health care system. Pharmacists, with their unique knowledge of medicine, are crucial in using pharmacoeconomic analysis to influence expenditure and distribution of resources on medicines. Design and management of pharmacoeconomic studies

·         cost and burden of illness studies,

·         drug utilization,

·         budget impact analysis,

·         modeling and simulations

are very important in today’s pharmaceutical market. Moreover pharmacoeconomic  approach towards  

  • Management of Consensus Meetings (Advisory Boards, Delphi Panels, etc.)
  • Re-analysis of trials
  • Implementation and customization with local data of pharmacoeconomic models

have greatly aided the pharma industries.

  • ROI: Return on Investment
  • Economic Evaluation Of Pharmaceuticals
  • Quality-Adjusted Life Years
  • Health Economics
  • Cost-Minimization Analysis
  • Cost-Benefit Analysis
  • Cost-Effectiveness Analysis
  • Cost-Utility Analysis
  • Pricing and Market Access

Related Conference of Pharmacoeconomics

June 06-07, 2018

International Conference & B2B on Pharma Research and Development

Philadelphia, Pennsylvania, USA
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 15-16, 2018

14th International Conference on Generic Drugs and Biosimilars

Frankfurt, Germany
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Pharmacoeconomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in